Biotech Values

[DewDiligence]

In other words, you’re saying that TAF failure should cause GILD to take a very large hit, but investors will likely underestimate the resulting damage to GILD’s business and hence the share price will not be affected as much as it ought to be if investors were acting logically. Is this correct?